Lamivudine therapy for hepatitis B virus reactivation in a patient receiving intra-arterial chemotherapy for advanced hepatocellular carcinoma

Hepatology Research

Volumn 26, Issue 1, 2003, Pages 77-80

  Tamori, Akihiro ^a   Nishiguchi, Shuhei ^a   Tanaka, Motoharu ^a   Kurooka, Hiroko ^a   Fujimoto, Shunsuke ^a   Nakamura, Kenji ^a   Shiomi, Susumu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Flare up; Hepatitis B e antigen; Seroconversion

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ALPHA2B INTERFERON; CISPLATIN; EPIRUBICIN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS DNA;

ADULT; ADVANCED CANCER; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; ENZYME ACTIVITY; FEMORAL ARTERY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEROCONVERSION; VIRUS REACTIVATION;

EID: 0043093720     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(03)00002-0     Document Type: Article

References (16)

1. Ikeda K, Saitoh S, Suzuki Y, et al. Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study. Cancer 1998;82:827-35.
2. Dienstag JL, Schiff ER, Wright TL, et al. Lamivudone as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999;341:1256-63.
3. Yeo W, Chan PK, Zhong S, et al. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. J Med Virol 2000;62:299-307.
4. Dai MS, Lu JJ, Chen YC, Perng CL, Chao TY. Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patients. Cancer 2001;92:2927-32.
5. Kanai N, Hasegawa K, Ogawa M, et al. Lamivudine treatment for acute exacerbation of hepatitis B in patients undergoing immunosuppressive therapy. Hepatol Res 2002;22:223-30.
6. Shiraki K, Hamada M, Sugimoto K, et al. Detection of precoremutant hepatitis B virus genome in patients with acute and fulminant hepatitis using mutation site-specific assay (MSSA). Hepatogastroenterology 2002;49:1352-6.
7. Kaneko S, Urabe T, Kobayashi K. Combination chemotherapy for advanced hepatocellular carcinoma complicated by major portal vein thrombosis. Oncology 2002;62(Suppl 1):69-73.
8. Yamasaki T, Kurokawa F, Shirahashi H, et al. Novel arterial infusion chemotherapy using cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma. Hepatol Res 2002;23:7-17.
9. Scherf U, Ross DT, Waltham M, et al. A gene expression database for the molecular pharmacology of cancer. Nat Genet 2000;24:236-44.
10. Kubo S, Nishiguchi S, Hamba H, et al. Reactivation of viral replication after liver resection in patients infected with hepatitis B virus. Ann Surg 2001;233:139-45.
11. Steinberg JL, Yeo W, Zhong S, et al. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role. J Med Virol 2000;60:249-55.
12. Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991;324:1699-704.
13. Asia hepatitis lamivudine study group, Lai CL, Chien RN, Leung NW, et al. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998;339:61-8.
14. Yao FY, Terrault NA, Freise C, Maslow L, Bass NM. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort. Hepatology 2001;34:411-6.
15. Tsang SW, Chan HL, Leung NW, et al. Lamivudine treatment for fulminant hepatic failure due to acute exacerbation of chronic hepatitis B infection. Aliment Pharmacol 2001;15:1737-44.
16. Cainelli F, Longhi MS, Concia E, Vento S. Failure of lamivudine therapy for chemotherapy-induced reactivation of hepatitis B. Am J Gastroenterol 2001;96:1651-2.